A liquid chromatography with tandem mass spectrometry method for quantitating total and unbound ceritinib in patient plasma and brain tumor
A rapid, sensitive, and robust reversed-phase liquid chromatography with tandem mass spectrometry method was developed and validated for the determination of total and unbound ceritinib, a second-generation ALK inhibitor, in patient plasma and brain tumor tissue samples. Sample preparation involved...
Main Authors: | Xun Bao, Jianmei Wu, Nader Sanai, Jing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-02-01
|
Series: | Journal of Pharmaceutical Analysis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095177917300953 |
Similar Items
-
Determination of unbound piperaquine in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry
by: Liusheng Huang, et al.
Published: (2022-11-01) -
Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients
by: Magdalena Bodnar-Broniarczyk, et al.
Published: (2022-03-01) -
Prediction Models for Brain Distribution of Drugs Based on Biomimetic Chromatographic Data
by: Theodosia Vallianatou, et al.
Published: (2022-06-01) -
Sensitive LC-MS/MS Methods for Amphotericin B Analysis in Cerebrospinal Fluid, Plasma, Plasma Ultrafiltrate, and Urine: Application to Clinical Pharmacokinetics
by: Leandro Francisco Pippa, et al.
Published: (2021-11-01) -
Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role
by: Li X, et al.
Published: (2021-07-01)